GlassScriptPhysician profile
Charles Franklin Gresham
NPI 1104322254
$1,242.24
in general payments reported to CMS, 2019-2025
11 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $38.91 · 2024: $431 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $513.70 | 2024-2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $291.68 | 2023-2025 | General - Kidney Stone Disease, Lithovue, Ams 700 |
| Teleflex LLC | $267.58 | 2024 | Urolift |
| Medical Device Business Services, INC. | $34.51 | 2025 | Motoband |
| Mimedx Group, INC. | $29.95 | 2025 | |
| Cook Medical LLC | $21.45 | 2024 | Cook |
| Laborie Medical Technologies Corp. | $18.66 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Conmed Corporation | $17.79 | 2024 | Airseal |
| Ferring Pharmaceuticals INC. | $16.76 | 2024 | Adstiladrin |
| Antares Pharma, INC. | $15.90 | 2025 | Xyosted |
| Urogen Pharma, INC. | $14.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Gresham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.